Drug Topics

DECEMBER 24, 2024

Check out this list of our top 5 most read COVID-19 stories from the year 2024.

460

460

Drug Topics

JULY 29, 2024

Check out this list of our top 10 most read stories from July 2024.

484

484

Drug Topics

OCTOBER 31, 2024

Presenters at the National Community Pharmacists Association 2024 Annual Convention and Expo discussed workflow and the future of pharmacy as a patient destination.

484

484

Drug Topics

OCTOBER 23, 2024

New research presented at AMCP Nexus 2024 highlighted the effectiveness and cost-effectiveness of various migraine treatments, including onabotulinumtoxinA and fremanezumab, as well as the importance of migraine education programs for improving patient outcomes.

474

474

Drug Topics

AUGUST 25, 2023

The new deadline to be in compliance with the requirements will be November 27, 2024.

FDA 469

FDA 469

Drug Topics

JUNE 26, 2024

Check out this list of our top 10 most read stories from June 2024.

386

386

Drug Topics

AUGUST 30, 2024

Checkout these important FDA updates from the month of August 2024.

FDA 307

FDA 307

Drug Topics

JULY 26, 2024

Check out these important FDA updates from the month of July 2024.

FDA 307

FDA 307

Drug Topics

SEPTEMBER 26, 2024

Check out this list of our top 10 stories from September 2024.

307

307

Drug Topics

AUGUST 28, 2024

Check out this list of our top 10 stories from August 2024.

307

307

Drug Topics

MARCH 19, 2024

Moderna, Merck, and Pfizer-BioNTech are leading the charge with new vaccines for respiratory viruses in development.

Vaccines 498

Vaccines 498

Drug Topics

SEPTEMBER 24, 2024

Check out these featured Drug Topics interviews from September 2024.

281

281

Drug Topics

OCTOBER 18, 2024

Researchers explored the efficacy of Pfizer-BioNTech’s updated COVID-19 vaccine for the 2023-2024 period and its efficacy in improving various patient outcomes.

Vaccines 307

Vaccines 307

Drug Topics

AUGUST 9, 2024

The composition of the latest flu vaccine has changed. Here’s what pharmacists need to know.

Vaccines 502

Vaccines 502

Drug Topics

APRIL 5, 2024

Drug Topics sat down with Douglas Hoey, CEO of NCPA, at the 2024 AAP annual conference to discuss how independent pharmacies are doing so far this year.

Independent Pharmacies 299

Independent Pharmacies 299

Drug Topics

OCTOBER 14, 2024

Research presented at ACCP 2024 found that addiction medicine consult services could help increase medication for opioid use disorder initiation.

307

307

Drug Topics

OCTOBER 22, 2024

Posters presented at IDWeek 2024 provided new insights into the impact of COVID-19 infection and vaccination on women’s health.

Vaccines 307

Vaccines 307

Drug Topics

NOVEMBER 6, 2024

Checkout some of the most important sessions and video interviews from the 2024 National Community Pharmacists Association (NCPA) Annual Convention and Expo.

247

247

Drug Topics

MARCH 14, 2025

A new report from the American Economic Liberties Project presents the continued challenges pharmacies face since Congress failure to pass PBM reform at the end of 2024.

569

569

Drug Topics

APRIL 12, 2024

Since a 2019 measles outbreak, the CDC has seen an increasing number of cases in the US.

503

503

Drug Topics

OCTOBER 16, 2023

Lisa Faast, CEO and Owner of DiversifyRx, discusses ways that pharmacists can prepare their business for the cash crunch that is set to happen in the first several months of next year.

568

568

Drug Topics

OCTOBER 22, 2024

Three posters showcased at IDWeek 2024 focused on enhancing access to HIV prevention and treatment, as well as increasing uptake of pre-exposure prophylaxis (PrEP) among women.

281

281

Drug Topics

JANUARY 1, 2025

Check out this list of our top 5 most read immunization stories from the year 2024.

Immunization 247

Immunization 247

Drug Topics

DECEMBER 30, 2024

Check out this list of our top 5 most read diabetes stories from the year 2024.

247

247

Drug Topics

DECEMBER 26, 2024

Check out this list of our top 5 most read cardiology stories from the year 2024.

247

247

Drug Topics

FEBRUARY 20, 2024

Drug Topics sat down with Jude Dieterman, CEO of Outcomes, to discuss the value and uniqueness of the company in the pharmacy market, what’s next on the horizon, and the upcoming event.

529

529

Drug Topics

OCTOBER 26, 2024

The Drug Enforcement Administration gives controlled substance licenses, and can just as easily take them away.

Controlled Substances 499

Controlled Substances 499

Drug Topics

OCTOBER 9, 2024

Two posters presented at the annual meeting of the American College of Chest Physicians, CHEST 2024, offered insights into the accurate diagnosis and appropriate treatment of ACOS.

281

281

Drug Topics

DECEMBER 29, 2024

Check out this list of our top 5 most read womens health stories from the year 2024.

247

247

Drug Topics

DECEMBER 25, 2024

Check out this list of our top 5 most read digestive health stories from the year 2024.

247

247

Drug Topics

DECEMBER 25, 2024

Check out this list of our top 5 most read Total Pharmacy stories from the year 2024.

247

247

Drug Topics

NOVEMBER 21, 2024

Research presented at American Heart Association’s 2024 Scientific Sessions examined the SGLT inhibitor’s effect on systolic blood pressure.

281

281

Drug Topics

SEPTEMBER 30, 2023

As the Southern Hemisphere sees a mixed flu season, uncertainty looms for those in the North.

469

469

Drug Topics

OCTOBER 21, 2024

Researchers explored the overall efficacy of various pediatric vaccines and their effects on antibiotic use, while also addressing vaccine hesitancy among parents.

Immunization 502

Immunization Vaccines 502

Drug Topics

APRIL 9, 2024

See what's trending in pharmacy with a preview of Drug Topics' April issue.

387

387

Drug Topics

MAY 23, 2024

In an abstract presented at Digestive Disease Week 2024, researchers analyzed the prevalence of obesity in patients with and without celiac disease.

580

580

PharmaVoice

OCTOBER 8, 2024

This year’s PharmaVoice 100 encompasses the industry’s ongoing revolutions and leaders who are not only navigating these changes, but at times, forging new paths for others to follow.

363

363